These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 14719175)

  • 21. Advances in hemophilia: experimental aspects and therapy.
    Rodriguez NI; Hoots WK
    Pediatr Clin North Am; 2008 Apr; 55(2):357-76, viii. PubMed ID: 18381091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family issues in continuous infusion therapy with factor VIII.
    Manco-Johnson MJ
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S21-5. PubMed ID: 8735793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemophilia gene transfer: comparison with conventional protein replacement therapy.
    Ragni MV
    Semin Thromb Hemost; 2004 Apr; 30(2):239-47. PubMed ID: 15118935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical services in the treatment of hemophiliac patients.
    Carlsson MS; Stenberg PB; Björnsson KA; Eklund LH
    Am J Hosp Pharm; 1993 Oct; 50(10):2073-6. PubMed ID: 8238051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hemophilias: progress and problems.
    Mannucci PM; Tuddenbam EG
    Semin Hematol; 1999 Oct; 36(4 Suppl 7):104-17. PubMed ID: 10595759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors.
    Johnson AJ; Mathews RW; Fulton AJ
    Clin Haematol; 1984 Feb; 13(1):3-15. PubMed ID: 6426834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gene therapy for hemophilia: feasible in principle but not yet clinically applicable].
    van der Eb MM; Schagen FH; van Ormondt H; Hoeben RC
    Ned Tijdschr Geneeskd; 1998 Apr; 142(15):840-4. PubMed ID: 9623157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing and maintaining of hemophilia programs in developing countries.
    Carman CJ
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():46. PubMed ID: 7886605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion-transmitted infection in hemophilia in developing countries.
    Yee TT; Lee CA
    Semin Thromb Hemost; 2005 Nov; 31(5):527-37. PubMed ID: 16276461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic infusion regimens in the management of hemophilia.
    Ljung RC
    Thromb Haemost; 1999 Aug; 82(2):525-30. PubMed ID: 10605746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation factors with improved properties for hemophilia gene therapy.
    Pipe SW
    Semin Thromb Hemost; 2004 Apr; 30(2):227-37. PubMed ID: 15118934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical gene transfer studies for hemophilia A.
    Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):249-56. PubMed ID: 15118936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for hemophilia A.
    Gan SU; Calne RY
    Discov Med; 2006 Oct; 6(35):198-202. PubMed ID: 17234142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic treatment for hemophilia A patients: a pilot study.
    Chuansumrit A; Isarangkura P; Hathirat P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):243-6. PubMed ID: 8629053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylactic replacement therapy in hemophilia. A case report (author's transl)].
    Mitterstieler G
    Padiatr Padol; 1976; 11(2-2):469-74. PubMed ID: 967509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemophilia A.
    Lusher JM; Warrier I
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1021-33. PubMed ID: 1400070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consideration in hemophilia therapy selection.
    Pipe S
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S23-7. PubMed ID: 16631824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New approaches to haemophilia treatment--recombinant and transgenic concentrates, gene therapy and engineered coagulation factors].
    Habart D
    Cas Lek Cesk; 2006; 145(2):104-11. PubMed ID: 16521398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemostasis: a practical review of conservative and operative care.
    Shopnick RI; Brettler DB
    Clin Orthop Relat Res; 1996 Jul; (328):34-8. PubMed ID: 8653974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.